TAK 083
Alternative Names: TAK-083Latest Information Update: 16 Feb 2006
At a glance
- Originator Takeda
- Class Antibacterials; Indoles
- Mechanism of Action RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Helicobacter infections
Most Recent Events
- 16 Feb 2006 No development reported - Preclinical for Helicobacter infections in Japan (unspecified route)
- 23 Oct 2001 A preclinical study has been added to the Bacterial Infections antimicrobial activity and pharmacodynamics sections
- 14 Sep 2001 Preclinical development for Helicobacter infections in Japan (Unknown route)